Quinidine, a tertiary amine compound with a site of ionization with a pK a value of pH 8.8, is classified as a type IA antiarrhythmic drug, and has been used for the management of ventricular arrhythmias.
The mechanism of intestinal absorption of lipophilic organic cations has been explained as passive diffusion of unionized compounds according to the pH-partition theory. On the other hand, Mizuuchi et al. investigated the mechanisms responsible for the transcellular transport of diphenhydramine in Caco-2 cells. 8, 9) This cell line forms confluent monolayers of well differentiated enterocyte-like cells with functional properties of transporting epithelia, and is widely used as a model to study the absorption of drugs and other xenobiotics. [10] [11] [12] The uptake of diphenhydramine at the apical membrane in Caco-2 cells was pH-and temperature-dependent, but was not inhibited by tetraethylammonium, biological amines, or neurotransmitters. 8) On the other hand, the uptake was inhibited by chlorpheniramine, procainamide, and imipramine, and was trans-stimulated by the preloading of chlorpheniramine, dimethylaminochloride, and triethylamine. 8, 9) From these results, Mizuuchi et al. concluded that the uptake of diphenhydramine at the apical membrane in Caco-2 cells is mediated by a specific transport system, and that this system recognizes the N-dimethyl or N-diethyl moieties of compounds. 8, 9) However, at present, it is unclear whether the transport system for diphenhydramine is involved in the intestinal absorption of other tertiary amine compounds, such as quinidine.
During drug absorption in the intestine, therapeutic compounds or nutrients first enter intestinal epithelial cells from their apical side, then pass through the epithelia to the basolateral side, and finally appear in the blood stream. Therefore, to investigate intestinal drug absorption, it is important to separately assess these sequential processes. However, in many cases, drug transport on the apical and basolateral sides of the monolayer in Caco-2 cells was not separately examined, and the influx and efflux clearance rates were not evaluated. 13) For the characterization of transcellular drug transport, a pharmacokinetic approach is useful. Transcellular drug transport in Caco-2 cell monolayers can be analyzed in detail in a model-dependent manner, where their drug concentration-time profiles on both sides of the monolayer can be assessed by curve fitting calculations and the influx and efflux clearance of the monolayer separately evaluated. In addition, when transcellular drug transport is examined under the condition where the unlabeled drug concentration in the monolayer is equilibrated with that of the incubation medium in the apical and basolateral chambers, the transport data for a small amount of radio-labeled drug can be analyzed using a linear pharmacokinetic model. 13) In the present study, to characterize the mechanism responsible for the intestinal absorption of a lipophilic organic cation, we performed a pharmacokinetic analysis of the transcellular transport of quinidine across Caco-2 cell monolayers. This analysis indicated that the influx clearance of quinidine at the apical membrane was much greater than any other clearance values of cell membranes. Therefore, we also investigated the uptake mechanism of quinidine at the apical membrane of Caco-2 cells grown on plastic dishes. Cell Culture and Preparation of Monolayers Caco-2 cells at passage 40 were obtained from the Riken Bioresource Center (Tsukuba, Japan), and all experiments were carried out with the cells between passages 47 to 65. The cells were maintained by serial passage in plastic dishes with Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Valley Biochemical Inc., Winchester, VA, U.S.A.) in an atmosphere of 5% CO 2 -95% air at 37°C. The medium was changed every second or third day, and when the cells reached 80-90% confluence, they were subcultured using a 0.02% EDTA/0.05% trypsin solution. 13) The cells were seeded at a density 5ϫ10 5 plastic dish using a Falcon ® multiwell TM plate (BD Bioscience), and were maintained for 21 d to investigate the transport mechanism of quinidine at the apical membrane.
MATERIALS AND METHODS

Materials
Pharmacokinetic Analysis of Transcellular Transport of Quinidine The transcellular transport of quinidine in Caco-2 cell monolayers prepared on a porous membrane was examined as described previously. 13) In brief, the monolayer was pre-incubated for 60 min at 37°C with culture medium containing unlabeled quinidine (100 nM-100 mM) to equilibrate the drug concentration. After the 60-min equilibration period, [ 3 H]quinidine (1-2.3 mCi/well) was applied to the apical chamber (1 ml) to examine the apical-to-basolateral transcellular transport of quinidine. A volume (50 ml) of medium in the basolateral chamber (2.3 ml) was then collected after 60, 120, and 180 min. Following the last collection, the Caco-2 cell monolayers on the porous membrane were immediately washed three times with ice-cold phosphate buffer, and the cells were collected. The amounts of [ 3 H]quinidine in the medium and cells were determined using a liquid scintillation counter, and normalized against the initially applied doses. The time course of the transport of quinidine in the opposite direction (basolateral-to-apical) was examined in the same manner.
The transcellular transport of quinidine was analyzed in a model-dependent manner using the NONMEM software running on a mainframe UNIX machine at the Kyoto University Data Processing Center, as described previously. 13) In brief, the following mass balance equations were prepared for the pharmacokinetic analysis:
where X A , X B , and X C are the amount of quinidine in the apical chamber, the basolateral chamber, and the monolayer determined at time t, respectively. V A and V B indicate the volume of the apical chamber (1 ml) and the basolateral chamber (2.3 ml), respectively. V C indicates the cell volume (2.25 ml), which was previously measured with sulfanilamide in our laboratory.
13) The influx and efflux clearance of quinidine on the apical membrane of the cells was designated as CL AC and CL CA , respectively. The influx and efflux clearance of quinidine on the basolateral membrane of the cells was designated as CL BC and CL CB , respectively. Paracellular transport clearance (CL PARA ) was fixed to 0.0141 ml/min (0.0157 ml/min/cm 2 ), which was obtained from the transport profile of mannitol.
13)
Cellular Uptake of Quinidine The cellular uptake of [ 3 H]quinidine was examined in the presence of 100 mM quinidine using Caco-2 cell monolayers prepared on plastic dishes of a multiwell plate. The composition of the incubation medium was as follows: 125 mM NaCl, 4.8 mM KCl, 5.6 mM D-glucose, 1.2 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 · 7H 2 O, 100 mM quinidine, and 25 mM HEPES (pH 7.4). In order to evaluate the effect of the medium's pH on the cellular uptake of [ 3 H]quinidine, 25 mM HEPES (pH 7.4 or 6.5) was replaced with 2-(N-morpholino)ethanesulfonic acid (pH 5.5), or Tris (pH 8.0). The monolayers were first pre-incubated for 60 min at 37°C or 4°C with 2 ml of incubation medium. To maintain the pH of the incubation medium, the apical medium was replaced with fresh incubation medium at 10 min before the addition of [ The effect of digitonin, carvedilol, rifamycin SV, and Lcarnitine on the apical uptake of [ 3 H]quinidine in Caco-2 cells was evaluated at 37°C in the presence of 100 mM quinidine. The incubation medium was replaced with fresh medium containing 40 mM digitonin, 50 mM carvedilol, 20 mM rifamycin SV, or 50 mM L-carnitine, at 10 min before the addition of [ 3 H]quinidine. [14] [15] [16] [17] The cells were incubated with also evaluated at 37°C in the presence of 100 mM quinidine. 8, 9, 18) The incubation medium was replaced with fresh medium containing 5 mM quinidine, 5 mM quinine, 20 mM diphenhydramine, 20 
RESULTS
Transcellular Transport and Cellular Accumulation of Quinidine in Caco-2 Cell Monolayers
We first examined the transcellular transport and cellular uptake of quinidine in Caco-2 cell monolayers. Figure 1 shows the transcellular transport profiles of [ 3 H]quinidine at concentrations of 100 nM, 10 mM, and 100 mM. Quinidine was transported in a direction-specific manner at the concentration of 100 nM, where the amount of quinidine transported in the apical-tobasolateral direction within 180 min was greater than that transported in the opposite direction (Fig. 1A) . Basolateralto-apical transport of quinidine was almost constant in the concentration range of 100 nM-100 mM. In constant, apicalto-basolateral transport of the drug was increased at 10 mM and 100 mM as compared with 100 nM (Fig. 1) . Table 1 shows the cellular accumulation of [ 3 H]quinidine after the 180-min transcellular transport. The amount of quinidine accumulated into cells from the apical medium was much greater than that from the basolateral medium (Table  1) . The cellular concentration of [ 3 H]quinidine at a drug concentration in the medium of 100 nM (2.72%/2.25 ml) was 13.4-fold higher than that in the apical medium (89.9%/ 1000 ml) after 180 min of apical-to-basolateral transport. The accumulation of [ 3 H]quinidine at the concentration of 10 mM was slightly higher than that at 100 nM and 100 mM, though the difference was not statistically significant (Table 1) .
Influx and Efflux Clearance of Quinidine in Caco-2 Cell Monolayers
To characterize the transcellular transport of quinidine in Caco-2 cell monolayers, we performed a pharmacokinetic analysis using the data on the transcellular transport and cellular accumulation of [ 3 H]quinidine. As shown in Table 2 , the mean efflux clearance of the apical membrane (CL CA ) was 6.1-fold greater than that of the basolateral membrane (CL CB ) at a drug concentration in the medium of 100 nM (0.238 vs. 0.039 ml/min/cm 2 ). CL CA at 10 mM was decreased by 32% as compared with that at 100 nM, indicating that the apical efflux of quinidine was partially saturated at the concentration of 10 mM. This finding was consistent with the result that the apical-to-basolateral transport of [ 3 H]quinidine was greater at 10 mM than 100 nM (Figs. 1A, B) . It was reported that P-glycoprotein (P-gp) is expressed on the apical membrane of Caco-2 cells, and that quinidine is a substrate of P-gp. 19, 20) Therefore, P-gp may be at least partially responsible for the CL CA value, and plays a role in the intestinal absorption of quinidine. On the other hand, CL CA and CL CB were increased significantly at a drug concentration of 100 mM as compared with 100 nM, which suggested that [ lar accumulation of quinidine after the apical-to-basolateral and basolateral-to-apical transport study at the drug concentration of 100 mM tended to be less than that at 10 mM ( Table  1) . As shown in Table 2 , the mean influx clearance of the apical membrane (CL AC ) was 5.4-fold greater than that of the basolateral membrane (CL BC ) at the drug concentration of 100 nM (3.75 vs. 0.689 ml/min/cm 2 ), and was much greater than any other clearance values including the CL PARA value (0.0157 ml/min/cm 2 ). In addition, CL AC was constant in the concentration range of 100 nM-100 mM, suggesting that the influx clearance at the apical membrane has the characteristics of low affinity and high capacity. The findings indicated that the influx of the apical membrane (CL AC ) was the primary factor, which was responsible for the greater apical-tobasolateral transport of quinidine across the intestinal epithelial cells (Fig. 1) .
Effect of pH and Temperature on Apical Uptake of Quinidine in Caco-2 Cell Monolayers
To characterize the transport of quinidine at the apical membrane of Caco-2 cells, the uptake of [ 3 H]quinidine was investigated using Caco-2 cell monolayers prepared on plastic dishes of a multiwell plate. As shown in Fig. 2 , the uptake of quinidine at 4°C was increased by the alkalization of the apical medium, but the profile was similar to that of the unionized fraction of quinidine calculated with the Henderson-Hasselbalch equation (Fig. 2) . The results indicated that passive diffusion of unionized quinidine is responsible for the uptake at the apical membrane at 4°C. On the other hand, the apical uptake was markedly increased by alkalization of the apical medium at 37°C. In addition, the uptake at 37°C was much greater than that at 4°C, indicating that some transport system was involved in the uptake of quinidine at the apical membrane of Caco-2 cells.
Effect of Various Compounds on Apical Uptake of Quinidine in Caco-2 Cell Monolayers
To elucidate the characteristics of quinidine's transport across the apical membrane of Caco-2 cells, the effect of digitonin, carvedilol, rifamycin SV, and L-carnitine on the apical uptake of quinidine was evaluated. Digitonin, a mild nonionic detergent that permeabilizes cellular membranes, 14) significantly decreased the uptake to 20% of the control value (Fig. 3) . The P-gp inhibitor carvedilol 15) did not affect the apical uptake of quinidine (Fig. 3) . In addition, rifamycin SV and L-carnitine, which were used as the organic anion-transporting polypeptide (OATP) inhibitor 16) and as an organic cation transporter (OCTN2) substrate, 17) respectively, had no effect on the uptake (Fig. 3) . These results suggested that some transport system contributes to the transport of quinidine into the cells, but that P-gp, OATPs, and OCTN2 are not involved in the apical uptake of quinidine in Caco-2 cells.
Furthermore, we examined the effect of tertiary amines and levofloxacin on the uptake of quinidine. As shown in Fig.  4 , diphenhydramine and levofloxacin significantly decreased the uptake to 5.2% and 6.4% of the control value, respectively. Quinidine, quinine, and imipramine also reduced uptake, though the difference was not statistically significant (Fig. 4) . These results suggested that the transport system for the apical uptake of quinidine is similar to that responsible for the transport of tertiary amines at the apical membrane of Caco-2 cells. 8, 9, 18) 
DISCUSSION
The present study had two major findings. First, the transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells was greater in the apical-tobasolateral direction than the opposite direction, mainly due to the large influx of the drug at the apical membrane of the cells. Second, the uptake of quinidine at the apical membrane was mediated by a temperature-sensitive specific transport 
system.
We previously investigated the transcellular transport of digoxin across Caco-2 cell monolayers, and found that the efflux of the drug at the apical membrane was the directionand rate-determining step in the large basolateral-to-apical transport of the drug as compared with the apical-to-basolateral transport.
13) P-gp is expressed at the apical membrane of Caco-2 cells, and the basolateral-to-apical transport of digoxin across cell monolayers is inhibited by typical inhibitors of P-gp, quinidine and carvedilol. 13, 19) We, therefore, thought that the efflux of digoxin at the apical membrane was mediated by P-gp. The present finding that the transcellular transport of quinidine was greater in the apical-to-basolateral direction than the opposite direction (Fig. 1) , suggests that the transport activity of P-gp for quinidine is weaker than that for digoxin although quinidine is a substrate for P-gp. 7) In addition, the calculated efflux clearance of the apical membrane (CL CA ) of quinidine at a concentration of 100 nM was 77% lower than that of digoxin at a concentration of 10 nM (0.238 vs. 1.02 ml/min/cm 2 ).
13) The mean CL CA value of quinidine was further decreased at 10 mM probably because of partial saturation of the P-gp activity, although the CL CA value was marginally increased at 100 mM probably because of the decreased intracellular binding of the drug (Table 2) . On the other hand, the influx clearance of the apical membrane (CL AC ) of quinidine was much greater than the other influx/efflux clearance values of cell membranes, suggesting that the influx at the apical membrane was the direction-determining step in the intestinal absorption (Table 2 ). In addition, the mean CL AC value of quinidine at 100 mM was 9.0-fold that of digoxin at 10 nM (3.98 vs. 0.44 ml/min/ cm 2 ), 13) which was consistent with the observation that the intestinal absorption of quinidine was very rapid and almost complete. 3, 4) In the present study, we evaluated the uptake of quinidine at the apical membrane in Caco-2 cell monolayers grown on plastic dishes, and found that this uptake was temperaturedependent and was decreased significantly in the presence of 20 mM diphenhydramine and 20 mM levofloxacin (Figs. 2, 4) .
These results suggested that the specific transport system for quinidine at the apical membrane of Caco-2 cells was similar to that of new quinolones as well as diphenhydramine. 8, 18) That is, the uptake of diphenhydramine and new quinolones at the apical membrane of Caco-2 cells was temperature-dependent. 8, 18) The uptake of diphenhydramine was significantly inhibited by chlorpheniramine (1-20 mM) and imipramine (5 mM), but not by biological amines or neurotransmitters. 8) On the other hand, the uptake of [ 14 C]levofloxacin was inhibited by grepafloxacin (10 mM), levofloxacin (20 mM), and quinidine (5 mM), but not by tetraethylammonium, p-aminohippurate, probenecid, amino acids, b-lactam antibiotic or monocarboxylates at a concentration of 10 mM. 18) However, in the present study, it is unclear whether the specific transport system for quinidine is identical to that for diphenhydramine and levofloxacin, and further investigation may be required to clarify the transport system for lipophilic organic cations in the human intestine.
In conclusion, our findings indicated that some specific transport system was involved in the influx of quinidine at the apical membrane of Caco-2 cells. This transport system may contribute to the rapid and almost complete absorption of quinidine from the human intestine. 
